APOLIPOPROTEIN B

Determination of apolipoprotein B (Apo B) level in human serum and plasma is used to assess the risk of heart disease (especially ischemic heart disease) on the atherosclerotic basis. Increased level of Apo B is observed in hyperlipidemia, coronary heart disease, diabetes, hypothyroidism, nephrotic syndrome, chronic renal failure, liver disease, biliary obstruction and Cushing's syndrome. A decrease in the concentration of Apo B occurs in hyperthyroidism, chronic anemia, malnutrition, intestinal malabsorption, inflammation and infections, Tangier disease.

Specification

Method

Immunoturbidimetric

Specimen

serum, plasma

On board stability

N/A

Calibration stability

N/A

Measuring range

0,019 – 4 g/l

Regulatory status

CE IVD

Reagent lines

  • Multipurpose Line

  • ACCENT-200

  • ACCENT-300

  • A-400

  • A-800

  • Prestige 24i
    Prestige 24i APOLIPOPROTEIN B (24 positions reagent tray)
    Prestige 24i APOLIPOPROTEIN B (36 positions reagent tray)

  • OS

Panels: cardiac, lipids, specific proteins

Available reagents

The specification was based on data determined on selected analyzers. We recommend that all users should refer to the instruction for use (IFU) and instruments’ user or service manuals before proceeding.

We Are Driven By Quality

Order this product

Order this product

To order this product, please contact your Area Sales Manager for details. If you have any questions, click the button below and fill out the form. We will contact you as soon as possible.

Contact

PZ Cormay S.A.

Ursynów Business Park
303 Pulawska Street
02-785 Warsaw, Poland